Shares of Avacta Group Plc (LON:AVCT - Get Free Report) shot up 13.2% during trading on Monday . The company traded as high as GBX 59.60 ($0.75) and last traded at GBX 58.93 ($0.74). 1,319,979 shares were traded during mid-day trading, an increase of 11% from the average session volume of 1,189,764 shares. The stock had previously closed at GBX 52.05 ($0.65).
Avacta Group Stock Up 9.5 %
The business's 50-day moving average is GBX 48.59 and its two-hundred day moving average is GBX 58.64. The firm has a market capitalization of £204.23 million, a price-to-earnings ratio of -633.33 and a beta of 1.12. The company has a debt-to-equity ratio of 63.54, a quick ratio of 4.96 and a current ratio of 1.29.
About Avacta Group
(
Get Free Report)
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Recommended Stories
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
